Agile Bio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 33

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 15

Agile Bio General Information

Description

Manufacturer of laboratory and bioprocess separation systems designed to enable efficient extraction, separation, and purification in biomedical and diagnostic workflows. The company offers separation materials, fluid automation systems, and online detection technologies with integrated automation and certified quality standards, enabling biopharmaceutical, clinical testing, and food testing laboratories to improve process accuracy, reliability, and operational efficiency in sample preparation and analysis.

Contact Information

Website
agilebio.com.cn
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Rooms 412 and 414, Building 2, Northwest Zone, Nano City
  • Number 99 Jinji Lake Avenue
  • Suzhou, Jiangsu 215000
  • China
+86 0512
Primary Industry
Medical Supplies
Other Industries
Other Commercial Products
Corporate Office
  • Rooms 412 and 414, Building 2, Northwest Zone, Nano City
  • Number 99 Jinji Lake Avenue
  • Suzhou, Jiangsu 215000
  • China
+86 0512

Agile Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Agile Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private 09-Apr-2026 Completed Generating Revenue
7. Later Stage VC (Series D) 08-Apr-2026 Completed Generating Revenue
6. Later Stage VC (Series C1) 31-Aug-2025 Completed Generating Revenue
5. Later Stage VC (Series C) 11-Feb-2025 Completed Generating Revenue
4. Early Stage VC (Series B) 31-Aug-2023 Completed Generating Revenue
3. Early Stage VC (Series A) 25-Mar-2022 Completed Generating Revenue
2. Early Stage VC 30-Dec-2021 Completed Generating Revenue
1. Early Stage VC 03-Mar-2021 Completed Generating Revenue
To view Agile Bio’s complete valuation and funding history, request access »

Agile Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Agile Bio Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Haihe River Industry Fund Fund of Funds Minority
HT CC Growth/Expansion Minority
Pudong Capital Venture Capital Minority
China Reform Holdings Corporation Corporation Minority
BGI Co-Win Corporate Venture Capital Minority
You’re viewing 5 of 15 investors. Get the full list »

Agile Bio FAQs

  • When was Agile Bio founded?

    Agile Bio was founded in 2020.

  • Where is Agile Bio headquartered?

    Agile Bio is headquartered in Suzhou, China.

  • What is the size of Agile Bio?

    Agile Bio has 33 total employees.

  • What industry is Agile Bio in?

    Agile Bio’s primary industry is Medical Supplies.

  • Is Agile Bio a private or public company?

    Agile Bio is a Private company.

  • What is Agile Bio’s current revenue?

    The current revenue for Agile Bio is .

  • How much funding has Agile Bio raised over time?

    Agile Bio has raised $27.6M.

  • Who are Agile Bio’s investors?

    Haihe River Industry Fund, HT CC, Pudong Capital, China Reform Holdings Corporation, and BGI Co-Win are 5 of 15 investors who have invested in Agile Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process